Viant Medical Inc. will close another manufacturing facility, this time in Tempe, Ariz.
The facility is expected to close in September but Plastics News couldn't confirm any timeline or the number of employees facing layoff.
Viant, called MedPlast Inc. until it rebranded in July 2018, has about 25 locations in the U.S., including several in the Western U.S., where Tempe workers can request transfers, according to Kathryn Misra, marketing director for South Plainfield, N.J.-based Viant.
"This was a very difficult strategic business decision made by Viant," Misra said in an email. "By integrating Tempe's programs into other Viant locations, we will be able create a dynamic synergy that will enhance the services provided to our customers."
Viant is a contract manufacturer of surgical instruments, orthopedic components, catheters, inhalers, insulin pens and other drug delivery devices.
With estimated sales of $310 million, Viant ranks No. 28 among North American injection molders in Plastics News' rankings.
Viant doubled in size in February 2017 with the acquisition the device manufacturing business of Vention Medical, which served many of the same customers.
The company then began shuttering some plants. In November 2018, the company closed its 85,000-square-foot facility in Monticello, Iowa, and laid off 70 employees after losing its largest customer.
About a year ago, Viant also closed a 60,000-square-foot facility in New Berlin, N.J., where it had 44 presses and offered molding, assembly, decorating and packaging. Some of those operations and personnel were consolidated into the South Plainfield plant about 70 miles away.
Viant also plans to close its sterilization operation in Grand Rapids, Mich., later this year as an investigation continues into air emissions of a carcinogen. The company has said that the closure and the investigation are not directly related.